Are you Dr. Langleben?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 23 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3535 Market St
Philadelphia, PA 19104Phone+1 215-746-6700- Is this information wrong?
Summary
- Dr. Daniel Langleben, MD is a board certified psychiatrist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, New Jersey, and West Virginia. He is affiliated with Hospital of the University of Pennsylvania and Philadelphia Veterans Affairs Medical Center.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Nuclear Medicine, 1997 - 1999
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Radiology-Diagnostic, 1993 - 1995
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Psychiatry, 1991 - 1993
- Drexel University College of Medicine/Hahnemann UniversityInternship, Transitional Year, 1990 - 1991
- The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1988
Certifications & Licensure
- CA State Medical License 1996 - 2024
- PA State Medical License 1990 - 2024
- WV State Medical License 2019 - 2024
- NJ State Medical License 2020 - 2021
- NY State Medical License 1993 - 1997
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Addiction Psychiatry
Clinical Trials
- CURE Addiction Center of Excellence: Brain Mechanisms of Relapse and Recovery Start of enrollment: 2012 Jan 01
- Brain Mechanisms of Pharmacotherapy in Opioid Use Disorder Start of enrollment: 2025 Feb 01
Publications & Presentations
PubMed
- Blood pressure response to extended-release naltrexone in heroin and prescription opioid users and its implications for cardiovascular morbidity.Zhenhao Shi, David Rott, Daniel D Langleben, Mark Albanese, Igor Elman> ;Journal of Addictive Diseases. 2024 Mar 31
- Hippocampal volume loss in individuals with a history of non-fatal opioid overdose.Dustin R Todaro, Xinyi Li, Laís S Pereira-Rufino, Peter Manza, Ilya M Nasrallah, Sandhitsu Das, Anna Rose Childress, Henry R Kranzler, Nora D Volkow, Daniel D Langlebe...> ;Addiction Biology. 2023 Oct 1
- Depressive Symptomatology Is Associated With Smaller Reductions in Drug Cue Reactivity During Extended-Release Naltrexone Treatment of Opioid Use Disorder.Zhenhao Shi, Xinyi Li, Kyle M Kampman, Anna Rose Childress, Corinde E Wiers, Daniel D Langleben> ;The Journal of Clinical Psychiatry. 2023 Apr 17
- Join now to see all
Press Mentions
- Is This Proof Brain Scans Can Read Our Minds? Special Type of MRI Translated Brainwaves into ImagesAugust 23rd, 2022
- Could Brain Scans Determine Guilt or Innocence in Court?November 10th, 2017
- The Problem of Lie DetectionNovember 15th, 2016
- Join now to see all
Grant Support
- Functional MRI Of Anti-Tobacco Public Service AnnouncementsNational Institute On Drug Abuse2007–2010
- Functional Neuromaging Of Cue-Induced Heroin CravingNational Institute On Drug Abuse2003–2007
Hospital Affiliations
- Philadelphia Veterans Affairs Medical CenterPhiladelphia, Pennsylvania
- Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania